ArticleHealth science reports2025

The Safety of Non-immunogenic Recombinant Staphylokinase in Elderly Patients With Massive Pulmonary Embolism: A Randomized Clinical Trial FORPE.

Stanislav G Leontyev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.